There is no single answer, because survival on continuous supplemental oxygen depends almost entirely on the lung or heart condition that made it necessary. People with chronic obstructive pulmonary disease (COPD) who use oxygen around the clock can live for many years, and the landmark trial that established this practice found that continuous oxygen roughly halved the death rate compared with nighttime-only use. By contrast, people who start oxygen for idiopathic pulmonary fibrosis (IPF) have a median survival of only about a year and a half from that point. The oxygen itself is not the limiting factor; the trajectory of the disease underneath it is.
The Trial That Changed Everything
The strongest evidence that 24/7 oxygen extends life comes from a 1980 clinical trial called the Nocturnal Oxygen Therapy Trial (NOTT). It enrolled COPD patients with severe, chronic low blood oxygen and randomly assigned them to receive oxygen either continuously (at least 19 hours a day) or only at night. The results were striking: the death rate in the nighttime-only group was nearly double that of the continuous group.1PubMed. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial That finding, confirmed by a parallel British trial around the same time, is still the backbone of guidelines that recommend long-term oxygen therapy (LTOT) for people with severely low oxygen levels.2PubMed Central. Long-term oxygen therapy in COPD patients: population-based cohort study on mortality
These trials gave a clear answer for a specific group: COPD patients whose resting blood oxygen is dangerously low benefit from wearing oxygen as many hours of the day as possible. “24/7” in clinical terms usually means at least 15 to 19 hours per day, though many patients end up using it around the clock simply because removing the cannula for extended periods makes them feel worse. The survival benefit grows the more hours per day the oxygen is used.
How Long People Live on Oxygen, by Condition
The question “how long” only makes sense once you know why someone is on oxygen. The prognosis varies enormously.
COPD
COPD is by far the most common reason for home oxygen therapy. Many people with COPD live five, ten, or more years after starting continuous oxygen, though individual outcomes depend on how severe the disease is, whether the person continues to smoke, and what other health problems they have. A population-based study found that even among COPD patients on LTOT, worse hypoxemia was associated with only a slightly higher risk of death, suggesting that once you are on oxygen and your levels are corrected, the remaining risk comes largely from factors beyond oxygen saturation alone.3PubMed. Hypoxemia severity and survival in ILD and COPD on long-term oxygen therapy – The population-based DISCOVERY study In other words, oxygen therapy levels the playing field to some extent, and what happens next depends on the overall state of your lungs, heart, and body.
Idiopathic Pulmonary Fibrosis
IPF is a progressive scarring disease of the lungs with no cure, and people who reach the point of needing oxygen tend to be in the later stages. A Japanese cohort study found that the median survival from the start of oxygen therapy was about 537 days, or roughly a year and a half.4PubMed Central. Cohort study to evaluate prognostic factors in idiopathic pulmonary fibrosis patients introduced to oxygen therapy Factors that predicted a shorter survival included lower body weight, worse lung function, and more severe drops in oxygen during a walking test. Some patients lived considerably longer, and some shorter, but the median gives a realistic baseline for what starting oxygen signals in IPF.
Pulmonary Arterial Hypertension
In pulmonary arterial hypertension (PAH), high blood pressure in the lung arteries strains the right side of the heart and eventually starves the body of oxygen. Data from a large U.S. registry showed that PAH patients with severely impaired gas exchange who used supplemental oxygen had a roughly 44% lower risk of death compared to similar patients who did not use it.5Journal of Heart and Lung Transplantation. Real-world supplemental oxygen use in pulmonary arterial hypertension: A Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL) analysis A smaller study found that about 81% of PAH patients on LTOT were alive at one year.6Indian Journal of Respiratory Care. Long-Term Oxygen Therapy in Patients with Pulmonary Artery Hypertension These numbers suggest oxygen helps, but the underlying disease still carries serious risk.
What Actually Determines How Long You’ll Live
Oxygen therapy corrects one problem: low blood oxygen. It does not reverse the disease that caused the low oxygen in the first place. This is the key distinction that shapes survival. A person with stable, moderate COPD who starts oxygen early and stops smoking may live for a decade or more. A person with rapidly progressing IPF or advanced PAH may have months. The oxygen keeps tissues alive and functioning, but it cannot repair scarred lung tissue or widen narrowed blood vessels.
Several factors matter beyond the diagnosis itself:
- Smoking status: Continuing to smoke while on oxygen dramatically worsens the prognosis for every lung condition and creates immediate fire hazards, discussed below.
- Exercise tolerance: How far you can walk and how much your oxygen drops during a walk test are strong predictors of survival in both IPF and COPD.
- Body weight: Being underweight is an independent risk factor for poor outcomes in both COPD and IPF.
- Comorbidities: Heart disease, diabetes, and other chronic conditions compound the risk independently of the lung disease.
- Adherence: Using oxygen for the prescribed number of hours matters. The NOTT trial showed that more hours of use meant a greater survival benefit, and skipping oxygen regularly erodes that advantage.
Effects on the Brain
One underappreciated benefit of continuous oxygen is what it does for thinking and memory. Chronic low blood oxygen starves the brain of what it needs to function, and over time this leads to measurable cognitive decline. A systematic review found that LTOT may help protect against this by improving blood flow and oxygen delivery to brain tissue.7PubMed Central. Long‐Term Oxygen Therapy and Cognitive Function in Chronic Obstructive Pulmonary Disease: A Systematic Review
The practical evidence backs this up. A study comparing COPD patients who regularly used supplemental oxygen to those who did not found that non-users scored significantly lower on standard cognitive screening tests. Not using oxygen also correlated with more emergency hospital visits and more hospitalizations in the prior year.8PubMed Central. Assessment of cognitive impairment in long-term oxygen therapy-dependent COPD patients For someone on 24/7 oxygen, this is encouraging: the therapy is not just keeping you alive but helping you stay mentally sharper than you would be without it.
What Daily Life Actually Looks Like
Living on oxygen around the clock is not just a medical question; it reshapes every part of daily routine. At home, a stationary oxygen concentrator plugs into the wall and runs continuously, pulling oxygen from room air and delivering it through a long tube connected to a nasal cannula. The tube can typically reach most rooms in a house, but it tangles on furniture and doorknobs, and the machine generates a constant low hum.
Leaving the house requires a portable oxygen concentrator (POC) or a tank of liquid oxygen. A study tracking real-world use of portable concentrators found that when patients were running on battery power, they were physically moving around about 42% of the time, suggesting the devices do enable meaningful activity outside the home.9PubMed Central. Patient Use Patterns of Portable Oxygen Concentrators A comparison of portable concentrators with liquid oxygen units during walking tests found no significant difference in exercise performance or breathlessness between the two, meaning the choice of device is more about convenience and weight than about clinical effectiveness.10PubMed. Comparing supplementary oxygen benefits from a portable oxygen concentrator and a liquid oxygen portable device during a walk test in COPD patients on long-term oxygen therapy
Despite the technology, social isolation is a real and well-documented problem. Research into patients’ experiences found that people on LTOT often felt restricted to their homes, had difficulty with mobility, and depended heavily on family members for basic activities. Even when a spouse or partner was present, feelings of isolation persisted.11PubMed. Patients’ experiences of long-term oxygen therapy The visible nasal cannula and the hiss of flowing oxygen become social markers that many patients find embarrassing, and some avoid going out rather than face questions or stares.
Quality of Life Is More Complicated Than It Sounds
You might expect that something life-saving would also make you feel better, but the relationship between oxygen therapy and quality of life is messier than the survival data suggests. A study measuring health-related quality of life found that patients starting LTOT had significantly worse scores across multiple domains compared to similar patients not yet on oxygen. After starting treatment, some dimensions improved, but gains in overall well-being and mood did not reach statistical significance.12Respiratory Medicine. Long-term oxygen therapy improves health-related quality of life
This does not mean oxygen makes things worse. It means that by the time someone needs 24/7 oxygen, their disease has progressed to a point where the therapy can hold the line but not reverse the accumulated burden. The oxygen relieves the acute distress of gasping for air, which patients consistently describe as the single most important benefit. But it does not eliminate fatigue, it does not restore the stamina of five years ago, and it comes with the daily hassle of managing equipment, refills, and tubing. For many people, the honest summary is that oxygen keeps them functional and alive, with a quality of life that is imperfect but far better than the alternative of untreated hypoxemia.
The Fire Risk That Nobody Wants to Talk About
Home oxygen does not explode on its own, but it dramatically accelerates burning. Oxygen-enriched air makes any flame or spark burn hotter and faster, and the consequences for someone wearing an oxygen cannula near a source of ignition can be catastrophic. A national analysis of burn admissions found that about 3% of burn hospitalizations with documented injury descriptions were caused by home oxygen therapy incidents. These patients had a median age of 65, a mean hospital stay of 8 days, and an inpatient mortality rate of about 6%.13PubMed. National Estimates and Outcomes for Supplemental Home Oxygen Therapy Injuries-A Burn Care Quality Platform Analysis
Smoking is the overwhelmingly dominant cause. One large review of burn registry data found that smoking accounted for 83% of home oxygen burn injuries, and that these injuries were associated with higher rates of inhalation injury and death compared to other burn causes.14PubMed. The National Incidence and Resource Utilization of Burn Injuries Sustained While Smoking on Home Oxygen Therapy A statewide analysis in one U.S. state estimated about 10 deaths per year from home oxygen fires, and smoking was identified as the cause in over 93% of fire deaths.15Journal of Burn Care & Research. 960 Statewide Landscape Analysis of Home Oxygen Therapy Related Fires and Burn Injuries The message is blunt: if you are on home oxygen and you smoke, you are at serious risk of dying in a fire. This is not a theoretical warning; it is one of the leading causes of preventable death among oxygen users.
Beyond cigarettes, other ignition sources like gas stoves and candles also pose risks, though at much lower rates. Keeping oxygen equipment at least ten feet from open flames, never using petroleum-based lotions near the cannula, and ensuring working smoke detectors throughout the home are standard safety precautions.
Can Too Much Oxygen Be Harmful?
The goal of oxygen therapy is to bring blood oxygen levels into a normal range, not to push them as high as possible. Giving too much oxygen, a state called hyperoxia, can cause real damage. Excess oxygen generates reactive molecules that injure cells, particularly in the lungs, a process broadly known as oxygen toxicity.16PubMed Central. Oxygen toxicity: cellular mechanisms in normobaric hyperoxia This is more of a concern in hospital settings where high-flow oxygen is delivered at concentrations far above what a home concentrator produces, but it is the reason that oxygen prescriptions specify a target range rather than “as much as possible.”
Guidelines differ slightly on exact targets. The Thoracic Society of Australia and New Zealand recommends keeping oxygen saturation between 92% and 96% for most adults, while the British Thoracic Society targets 94% to 98%.17PubMed. Target oxygen saturation range: 92-96% Versus 94-98 For people with COPD and chronic respiratory failure, the target is often set lower, around 88% to 92%, because pushing too high can paradoxically suppress the drive to breathe. The practical takeaway is that the flow rate on your concentrator should be set by your doctor and not turned up on your own initiative. More is not better, and in certain situations, more is actively dangerous.
Oxygen at the End of Life
For people in the final stages of lung disease or advanced cancer, continuous oxygen is sometimes used primarily to ease the distress of breathlessness rather than to extend survival. The evidence here is less clear-cut. Guidelines emphasize that home oxygen is most clearly beneficial when chronic low blood oxygen has been documented, but clinicians routinely make individual decisions based on what relieves symptoms for a particular patient, even when the standard criteria are not met.18PubMed Central. Oxygen therapy in palliative care
In palliative care, the question shifts from “how long will I live on oxygen” to “will oxygen make me more comfortable.” For some dying patients, oxygen eases the sensation of air hunger and reduces panic. For others, a fan blowing cool air across the face provides similar relief with less equipment. The decision to continue or stop oxygen near the end of life is deeply individual, and good palliative care teams revisit it regularly as symptoms change.
The Burden on Caregivers
An often-overlooked dimension of living on 24/7 oxygen is what it demands of the people around the patient. Caregivers of people with refractory breathlessness report the experience as extremely distressing, and research has found that they tend to overestimate the benefits of oxygen therapy while underestimating its potential downsides.19Journal of Pain and Symptom Management. Caregivers’ Perspectives on the Use of Long-Term Oxygen Therapy for the Treatment of Refractory Breathlessness: A Qualitative Study This mismatch can create tension: a caregiver may insist on keeping the oxygen running at all times because they equate it with survival, even when the patient finds the equipment intrusive or when clinical benefit is uncertain.
Managing equipment, coordinating refills, handling emergency situations when the power goes out, and watching someone you love struggle to breathe despite doing everything right all take a psychological toll. Caregivers of LTOT patients report higher rates of anxiety, sleep disruption, and social withdrawal. If you are caring for someone on continuous oxygen, asking for support from respiratory therapy teams, palliative care specialists, or caregiver support groups is not a sign of failure. The burden is real, and it is shared by nearly every family dealing with advanced lung disease.
Nocturnal Oxygen for Sleep Apnea
Continuous positive airway pressure (CPAP) is the standard treatment for obstructive sleep apnea, but some patients cannot tolerate it. In those cases, nocturnal oxygen therapy is sometimes used as an alternative or adjunct. A systematic review and meta-analysis found that overnight oxygen significantly reduced the frequency of breathing interruptions during sleep, cutting events by about 15 per hour compared to sham treatment. It also produced small but meaningful reductions in blood pressure over time.20PubMed Central. Nocturnal oxygen therapy in obstructive sleep apnoea: a systematic review and meta-analysis This is a different context from 24/7 use for lung disease, but it illustrates how supplemental oxygen can serve varied roles depending on the clinical situation. Nocturnal oxygen for sleep apnea does not address the airway collapse itself, which is why it remains a second-line option, but it can reduce the downstream oxygen drops that cause cardiovascular strain overnight.